Accolade to Participate in the Credit Suisse 30th Annual Healthcare Conference
Accolade, Inc. - common stock (ACCD)
Company Research
Source: GlobeNewswire
SEATTLE, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves over 400 employers and millions of members, will participate in the Credit Suisse 30th Annual Healthcare Conference, including a fireside chat presentation on Thursday, November 11, 2021 at 12:10 p.m. E.T. A webcast and related presentation materials will be available at ir.accolade.com. About Accolade, Inc. Accolade (Nasdaq: ACCD) provides millions of people and their families with an exceptional healthcare experience that is personal, data driven and value based to help every person live their healthiest life. Accolade solutions combine virtual primary care, mental health support and expert medical opinion services with intelligent technology and best-in-class care navigation. Accolade's Personalized Healthcare approach puts humanity back in healthcare by building relationships that connect people and their families to the right care at the right time to improve outcomes,
Show less
Read more
Impact Snapshot
Event Time:
ACCD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACCD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACCD alerts
High impacting Accolade, Inc. - common stock news events
Weekly update
A roundup of the hottest topics
ACCD
News
- Accolade, Inc. (NASDAQ: ACCD) had its price target lowered by analysts at Stifel Nicolaus from $15.00 to $13.00. They now have a "buy" rating on the stock.MarketBeat
- Accolade: Staying Bullish On Favorable Developments [Seeking Alpha]Seeking Alpha
- Accolade to Announce Fiscal Fourth Quarter 2024 Financial ResultsGlobeNewswire
- Recent uptick might appease Accolade, Inc. (NASDAQ:ACCD) institutional owners after losing 24% over the past year [Yahoo! Finance]Yahoo! Finance
- Accolade Wins 2024 Artificial Intelligence Excellence Award [Yahoo! Finance]Yahoo! Finance
ACCD
Earnings
- 1/8/24 - Beat
ACCD
Sec Filings
- 4/19/24 - Form 4
- 4/19/24 - Form 4
- 4/19/24 - Form 4
- ACCD's page on the SEC website